SOURCE: GeneThera, Inc.

April 02, 2007 10:12 ET

Court Allows Private Testing for Mad Cow Disease

WHEAT RIDGE, CO -- (MARKET WIRE) -- April 2, 2007 -- GeneThera, Inc. (OTCBB: GTHA) today announced that on Thursday March 29, 2007, a federal judge ruled that the federal government must allow meatpackers to test their animals for Mad Cow Disease. Kansas meatpacker Creekstone Farms Premium Beef wants to test all of its cows for the disease, a move that larger companies feared. If Creekstone is allowed to advertise its meat as tested and safe it could essentially force the larger companies to test also.

Commenting on the news Dr. Tony Milici CEO of GeneThera said, "We are very encouraged and excited by Judge Robertson's decision. We believe that this ruling is a critical first step to finally determine the true extent of Mad Cow Disease in the US. Allowing private companies to test for Mad Cow Disease will also ensure greater transparency in the testing process and better access to information for the consumers."

U.S. District Judge James Robertson ruled that the government does not have the authority to regulate the test. Robertson put his order on hold until the government can appeal. If the government does not appeal by June 1, 2007, he stated the ruling would take effect.

The Agriculture Department currently regulates the test and administers it to about 1 percent of slaughtered cows for the disease. The department threatened Creekstone with prosecution, if it tested all of its animals.

ABOUT GENETHERA, INC.:

GeneThera, Inc. is a molecular biotechnology company located in Wheat Ridge, CO. The Company provides genetic diagnostic solutions for the veterinary and agricultural industries with future plans to include the health-care industry. The Company's proprietary diagnostic solution is based on a genetic expression assay, GEA™, a protocol designed to function on a highly automated Fluorogenic PCR platform. This platform enables GeneThera to offer tests that are presently not available from other technologies. The GEA is designed for a host of individual diseases, the current priority being Mad Cow Disease, Chronic Wasting Disease, a disease affecting elk and deer in North America; E.Coli 0157:H7 and Johnne's Disease, diseases affecting cattle worldwide.

"Safe Harbor" Statement: Certain statements in this release are "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Such statements are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the Company's ability to meet the terms and conditions required to obtain its project financing, risks and delays associated with product development, risk of market acceptance of new products, risk of technology or product obsolescence, competitive risks, reliance on development partners and the need for additional capital.

Contact Information